Company / Depreciation & Amortization
Illumina, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$270.0M
FY2025
5-year range
$187.0M / $432.0M
FY2021-FY2025
Trend
-23.7%
vs FY2024
Sector context
#38 of 141
Health Care
What the data says
At $270M, Illumina, Inc.'s depreciation & amortization ranks #104 of 141 in the Health Care sector. Depreciation & Amortization has fluctuated over the past 10 years, ranging from $127M in FY2017 to $432M in FY2023.
Based on SEC 10-K filings.
$270M in FY2025 with a 5-year CAGR of +7.6%.
Improved from $432M to $270M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +13.0%
- 5-Year CAGR
- +7.6%
- 10-Year CAGR
- -
Sector benchmark
#104 of 141 in Health CareTop 73% of 141This company $270.0M Sector average $344.6M
▼
-21.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.6%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 23.7% year-over-year.
- Ranks #38 out of 141 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $270.0M | -23.7% |
| FY2024 | $354.0M | -18.1% |
| FY2023 | $432.0M | +131.0% |
| FY2022 | $187.0M | -25.5% |
| FY2021 | $251.0M | +34.2% |
| FY2020 | $187.0M | +19.9% |
| FY2019 | $156.0M | +10.6% |
| FY2018 | $141.0M | +11.0% |
| FY2017 | $127.0M | -9.9% |
| FY2016 | $141.0M | +11.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026